Polymer-based vehicles for therapeutic peptide delivery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Therapeutic delivery

• Publication date

  2015-11-24

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.4155/tde.15.71PMID 26599420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PEGylated insulin Lispro (LY2605541): clinical overview of a new long-acting basal insulin analog in the treatment of Type 2 diabetes mellitus

  2015cited by this paper
• Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers.

  2015cited by this paper
• Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.

  2015cited by this paper
• Peptide therapeutics: current status and future directions.

  2015cited by this paper
• Challenges in the delivery of peptide drugs: an industry perspective.

  2015cited by this paper
• PEGylation of the peptide Bac7(1-35) reduces renal clearance while retaining antibacterial activity and bacterial cell penetration capacity.

  2015cited by this paper
• Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.

  2015cited by this paper
• The emergence of peptides in the pharmaceutical business: From exploration to exploitation

  2014cited by this paper
• Multifunctional polymeric micelles for delivery of drugs and siRNA

  2014cited by this paper
• Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity.

  2014cited by this paper
• Design and processing of nanogels as delivery systems for peptides and proteins.

  2014cited by this paper
• Recent developments in protein and peptide parenteral delivery approaches.

  2014cited by this paper
• Drug carriers for the delivery of therapeutic peptides.

  2014cited by this paper
• Injectable controlled release depots for large molecules.

  2014cited by this paper
• Agile delivery of protein therapeutics to CNS.

  2014cited by this paper
• Emerging methods for the fabrication of polymer capsules.

  2014cited by this paper
• Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.

  2013cited by this paper
• Nanoaggregates based on new poly-hydroxyethyl-aspartamide copolymers for oral insulin absorption.

  2013cited by this paper
• Hydrogel: Preparation, characterization, and applications: A review

  2013cited by this paper
• A new hyaluronic acid pH sensitive derivative obtained by ATRP for potential oral administration of proteins.

  2013cited by this paper
• Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.

  2013cited by this paper
• Pullulan-based nanoparticles as carriers for transmucosal protein delivery.

  2013cited by this paper
• Future directions for peptide therapeutics development.

  2013cited by this paper
• In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins.

  2013cited by this paper
• LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.

  2013cited by this paper
• Self-assembled PAA-based nanoparticles as potential gene and protein delivery systems.

  2013cited by this paper
• Exenatide and the treatment of patients with Parkinson's disease.

  2013cited by this paper
• Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.

  2013cited by this paper
• Injectable implants for the sustained release of protein and peptide drugs.

  2013cited by this paper
• Chitosan-based drug nanocarriers: where do we stand?

  2012cited by this paper
• Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

  2012cited by this paper
• In situ forming implants - an attractive formulation principle for parenteral depot formulations.

  2012cited by this paper
• Oral Delivery of Peptide Drugs

  2012cited by this paper
• Drug Delivery Systems to Fight Cancer

  2012cited by this paper
• Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system.

  2012cited by this paper
• An overview of natural polymers for oral insulin delivery.

  2012cited by this paper
• A 12-month phase 3 study of pasireotide in Cushing's disease.

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Polymer-based oral peptide nanomedicines.

  2012cited by this paper
• Hetero‐difunctional dimers as building blocks for the synthesis of poly(amidoamine)s with hetero‐difunctional chain terminals and their derivatives

  2012cited by this paper
• Peptide delivery using phospholipid micelles.

  2012cited by this paper
• Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.

  2012cited by this paper
• Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.

  2011cited by this paper
• A Novel Peptide Nanomedicine Against Acute Lung Injury: GLP-1 in Phospholipid Micelles

  2011cited by this paper
• Folate-decorated nanogels for targeted therapy of ovarian cancer.

  2011cited by this paper
• A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.

  2011cited by this paper
• In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• Micellar nanomedicine of human neuropeptide Y.

  2011cited by this paper
• Microgels and microcapsules in peptide and protein drug delivery.

  2011cited by this paper
• Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.

  2011cited by this paper
• Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.

  2011cited by this paper
• Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.

  2011cited by this paper
• Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.

  2011cited by this paper
• Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.

  2010cited by this paper
• Polypeptide-polymer bioconjugates.

  2010cited by this paper
• Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.

  2010cited by this paper
• Biodegradable polymeric nanoparticles based drug delivery systems.

  2010cited by this paper
• Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.

  2010cited by this paper
• Delivery of therapeutic proteins.

  2010cited by this paper
• Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation

  2010cited by this paper
• Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs

  2010cited by this paper
• Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.

  2010cited by this paper
• Poly(alkycyanoacrylate) nanoparticles for enhanced delivery of therapeutics – is there real potential?

  2009cited by this paper
• Self-assembled nanogel of hydrophobized dendritic dextrin for protein delivery.

  2009cited by this paper
• Nanogels as pharmaceutical carriers: finite networks of infinite capabilities.

  2009cited by this paper
• Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.

  2009cited by this paper
• In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.

  2009cited by this paper
• Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.

  2009cited by this paper
• A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules.

  2009cited by this paper
• PEGylation for improving the effectiveness of therapeutic biomolecules.

  2009cited by this paper
• Poly(alkylcyanoacrylate) nanoparticles for enhanced delivery of therapeutics - is there real potential?

  2009cited by this paper
• Obstacles and pitfalls in the PEGylation of therapeutic proteins.

  2008cited by this paper
• Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.

  2008cited by this paper
• How to achieve sustained and complete protein release from PLGA-based microparticles?

  2008cited by this paper
• Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy.

  2008cited by this paper
• Discovering and improving novel peptide therapeutics.

  2008cited by this paper
• Preparation and in vitro Evaluation of Linear and Star-branched PLGA Nanoparticles for Insulin Delivery

  2008cited by this paper
• Optimized preparation of insulin-lauryl sulfate complex loaded poly (lactide-co-glycolide) nanoparticles using response surface methodology.

  2008cited by this paper
• Polyion Complex Micelles Possessing Thermoresponsive Coronas and Their Covalent Core Stabilization via “Click” Chemistry

  2008cited by this paper
• The development of microgels/nanogels for drug delivery applications

  2008cited by this paper
• Intracellular delivery of protein and peptide therapeutics.

  2008cited by this paper
• Peptide/protein-polymer conjugates: synthetic strategies and design concepts.

  2008cited by this paper
• Biodegradable Polymer Based Particulate Carrier(s) for the Delivery of Proteins and Peptides

  2008cited by this paper
• A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.

  2007cited by this paper
• Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.

  2007cited by this paper
• Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.

  2007cited by this paper
• Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery

  2007cited by this paper
• Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor.

  2007cited by this paper
• A macrophage-nanozyme delivery system for Parkinson's disease.

  2007cited by this paper
• Multifunctional Nanoparticulate Polyelectrolyte Complexes

  2007cited by this paper
• Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.

  2007cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.

  2006cited by this paper
• Amphiphilic poly(D,L-lactic acid)/poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs.

  2006cited by this paper
• Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.

  2006cited by this paper
• Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.

  2006cited by this paper
• Translating peptides into small molecules.

  2006cited by this paper
• Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.

  2006cited by this paper
• Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.

  2006cited by this paper

• Polymersomes for Therapeutic Protein and Peptide Delivery: Towards Better Loading Properties

  2024cites this paper
• Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived

  2024cites this paper
• Trends in peptide drug discovery

  2021cites this paper
• Therapeutic peptide delivery via aptamer-displaying, disulfide-linked peptide amphiphile micelles

  2020cites this paper
• Bioresorbable and degradable behaviors of PGA : Current state and future prospects

  2020cites this paper
• A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics

  2017cites this paper